Skip to main content
OpenTrials
Completed

NCT Number: NCT00735657

Anesthesia for Pars Plana Vitrectomy (PPV) With Insulin Needle

Periocular blockade with 12.5 mm needle is as effective as block with 25 mm needle for patients undergoing Pars Plana Vitrectomy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

King Khaled Eye Specialist hospital

Riyadh, 11462, Saudi Arabia

About this study

The author wants to see the effect of short needle in patients undergoing retinal surgery.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients undergoing pars plana vitrectomy under local anesthesia

Exclusion criteria

  • Patients allergic to local anesthetic solutions
  • With local sepsis
  • Serious impairment of coagulation
  • Orbital abnormalities
  • Unable to cooperate in maintaining a relatively motionless supine position
  • Who refused the anesthetic technique

Treatment and study plan

needle

Device

Peribulbar blockade with standard (25 mm) needle

Other names: Peribulbar blockade with standard needle

pars plana vitrectomy

Procedure

Peribulbar block

Other names: Extraconal block

Primary outcomes

  1. Efficacy of insulin needle.

    Time frame: 1 year

Sponsors and collaborators

Lead sponsor

King Khaled Eye Specialist Hospital

Other Gov

Registry information

Official study title

Anesthesia for PPV Using Insulin Needle

Important dates

Study start
2008
Primary completion
2009
Study completion
2010
First posted
Aug 15, 2008
Registry last updated
Dec 2, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.